See more : Epazz, Inc. (EPAZ) Income Statement Analysis – Financial Results
Complete financial analysis of MedGen, Inc. (MDIN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MedGen, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- San Miguel Food and Beverage, Inc. (SMPFF) Income Statement Analysis – Financial Results
- Spacetalk Limited (SPA.AX) Income Statement Analysis – Financial Results
- Reply S.p.A. (0RV0.L) Income Statement Analysis – Financial Results
- Jianpu Technology Inc. (ADRs) (US47738D3098.SG) Income Statement Analysis – Financial Results
- Green Hydrogen Systems A/S (GREENH.CO) Income Statement Analysis – Financial Results
MedGen, Inc. (MDIN)
About MedGen, Inc.
As of June 25, 2020, 9430075 Canada Ltd. was acquired by MedGen, Inc. in a reverse merger transaction. 9430075 Canada Ltd. operates an online health and wellness platform that helps consumers find the vital health information and referrals they need; and health and wellness professional to navigate to clients directly. The company was incorporated in 2015 and is based in Winnipeg, Canada.
| Metric | 2019 | 2017 | 2016 |
|---|---|---|---|
| Revenue | 1.05 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.05 | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 16.43 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 16.43 | 2.67K | 170.00K |
| Other Expenses | 0.17 | 0.00 | 0.00 |
| Operating Expenses | 16.59 | 2.67K | 170.00K |
| Cost & Expenses | 16.59 | 2.67K | 170.00K |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 67.59K | 199.20K |
| Depreciation & Amortization | 0.17 | 0.00 | 0.00 |
| EBITDA | -15.37 | -2.67K | -170.00K |
| EBITDA Ratio | -1,462.80% | 0.00% | 0.00% |
| Operating Income | -15.54 | -2.67K | -170.00K |
| Operating Income Ratio | -1,478.50% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | -4.64K | -389.68K |
| Income Before Tax | -15.54 | -7.31K | -559.68K |
| Income Before Tax Ratio | -1,478.50% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 |
| Net Income | -15.54 | -7.31K | -559.68K |
| Net Income Ratio | -1,478.50% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 3.11M | 2.87B | 2.87B |
| Weighted Avg Shares Out (Dil) | 3.01M | 2.87B | 2.87B |
Source: https://incomestatements.info
Category: Stock Reports